Peter S. Sever

116 papers receiving 3.9k citations

Peter S. Sever's Hit Papers

Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial 2017 · 425 citations
4250+3+6Years since publication100200300400

Peers

Peter S. Sever
Comparison fields: 5 of 133
  • Surgery 1.8k
  • Cardiology and Cardiovascular Medicine 847
  • Endocrinology, Diabetes and Metabolism 643
  • Cellular and Molecular Neuroscience 413
  • Cancer Research 238
Replace Ross D. Feldman with:
Ross D. Feldman Canada
Kenneth M. Verburg United States
R. Paoletti Italy
Michael Schächter United Kingdom
Sven Waßmann Germany
Kikuo Arakawa Japan
Barry J. Gertz United States
Stella Trompet Netherlands
Reijo Laaksonen Finland
Bobby V. Khan United States
Peter S. Sever relative to Ross D. Feldman Canada Ross D. Feldman's profile →
Citations per field
00.5×3.5×
Ross D. Feldman · 1×
Citations per year

Countries citing papers authored by Peter S. Sever

Since Specialization
Citations

This map shows the geographic impact of Peter S. Sever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter S. Sever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter S. Sever more than expected).

Fields of papers citing papers by Peter S. Sever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter S. Sever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter S. Sever. The network helps show where Peter S. Sever may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter S. Sever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter S. Sever Line = papers co-authored together Peter S. Sever links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Hit paper breakdown →
2017491
2
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
Hit paper breakdown →
2017425
3
Cognitive Function in a Randomized Trial of Evolocumab
Hit paper breakdown →
2017347
4 2020126
5 2017104
6 2018101
7 201187
8 202083
9 197783
10 198883
11 198779
12 199477
13 202066
14 199663
15 197460
16 198654
17 201852
18 200550
19 201850
20 198349

About Peter S. Sever

Peter S. Sever is a scholar working on Surgery, Molecular Biology, Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience and Physiology, having authored 120 papers that have together received 4.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (29 papers), Receptor Mechanisms and Signaling (15 papers), Nitric Oxide and Endothelin Effects (11 papers), Blood Pressure and Hypertension Studies (9 papers), Neuropeptides and Animal Physiology (9 papers), Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Heart Rate Variability and Autonomic Control (6 papers). The work is most often cited by research in Surgery (1.8k citations), Cardiology and Cardiovascular Medicine (847 citations), Endocrinology, Diabetes and Metabolism (643 citations), Cellular and Molecular Neuroscience (413 citations) and Cancer Research (238 citations). Peter S. Sever has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Anthony Keech, Robert P. Giugliano, Marc S. Sabatine, Terje R. Pedersen, Michael Schächter, Alun D. Hughes, Scott M. Wasserman, Armando Lira Pineda, Narimon Honarpour and Ioanna Gouni‐Berthold. Their work appears in journals such as Journal of Hypertension, Biochemical Society Transactions, Circulation, Journal of Cardiovascular Pharmacology and JAMA Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact